These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 18777298)

  • 41. Efficacy in chickens of a herpesvirus of turkeys recombinant vaccine containing the fusion gene of Newcastle disease virus: onset of protection and effect of maternal antibodies.
    Morgan RW; Gelb J; Pope CR; Sondermeijer PJ
    Avian Dis; 1993; 37(4):1032-40. PubMed ID: 8141730
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Duration of vaccinal immunity against Marek's disease.
    Witter RL; Offenbecker L
    Avian Dis; 1978; 22(3):396-408. PubMed ID: 211999
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of factors influencing replication of serotype 1 Marek's disease vaccines in the chicken lung.
    Gimeno IM; Cortes AL
    Avian Pathol; 2010 Apr; 39(2):71-9. PubMed ID: 20390540
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Acid alpha naphthyl acetate esterase reacting lymphocytes in the peripheral blood of chickens challenged with Marek's disease after vaccination with three different vaccines.
    Pruthi AK; Gupta RK; Sadana JR
    Res Vet Sci; 1987 Jul; 43(1):92-6. PubMed ID: 3628992
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of the protection elicited by direct and indirect exposure to live attenuated infectious laryngotracheitis virus vaccines against a recent challenge strain from the United States.
    Rodríguez-Avila A; Oldoni I; Riblet S; Garcia M
    Avian Pathol; 2008 Jun; 37(3):287-92. PubMed ID: 18568655
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Influence of serotype and virus strain on synergism between Marek's disease vaccine viruses.
    Witter RL
    Avian Pathol; 1992 Dec; 21(4):601-14. PubMed ID: 18670978
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Protection and immune response in pigs intradermally vaccinated against porcine reproductive and respiratory syndrome (PRRS) and subsequently exposed to a heterologous European (Italian cluster) field strain.
    Martelli P; Cordioli P; Alborali LG; Gozio S; De Angelis E; Ferrari L; Lombardi G; Borghetti P
    Vaccine; 2007 Apr; 25(17):3400-8. PubMed ID: 17276558
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pathogenicity of a Marek's disease virus for chickens vaccinated with graded doses of herpesvirus of turkeys.
    Cauchy L; Coudert F; Dambrine G
    Avian Dis; 1979; 23(4):821-30. PubMed ID: 546406
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Protection and synergism by recombinant fowl pox vaccines expressing genes from Marek's disease virus.
    Nazerian K; Witter RL; Lee LF; Yanagida N
    Avian Dis; 1996; 40(2):368-76. PubMed ID: 8790888
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lack of a threshold of genetic resistance to Marek's disease and the incidence of humoral antibody.
    Sharma JM
    Avian Pathol; 1973 Apr; 2(2):75-90. PubMed ID: 18777387
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy and safety of a cell-culture live virus vaccine for hemorrhagic enteritis of turkeys: laboratory studies.
    Fadly AM; Nazerian K
    Avian Dis; 1984; 28(1):183-96. PubMed ID: 6326740
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characteristics of CVI988/Rispens and R2/23, two prototype vaccine strains of serotype 1 Marek's disease virus.
    Witter RL; Lee LF; Fadly AM
    Avian Dis; 1995; 39(2):269-84. PubMed ID: 7677647
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Herpesvirus of turkey recombinant viruses expressing infectious bursal disease virus (IBDV) VP2 immunogen induce protection against an IBDV virulent challenge in chickens.
    Darteil R; Bublot M; Laplace E; Bouquet JF; Audonnet JC; Rivière M
    Virology; 1995 Aug; 211(2):481-90. PubMed ID: 7645252
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effect of Marek's disease vaccination on the immunisation of day-old chicks against Newcastle disease, using B1 and oil emulsion vaccine.
    Box PG; Furminger IG; Robertson WW; Warden D
    Avian Pathol; 1976; 5(4):299-305. PubMed ID: 18777359
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Further characterisation of the CVI 988 strain of Marek's disease virus.
    Bülow VV
    Avian Pathol; 1977; 6(4):395-403. PubMed ID: 18770348
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Characterization of very virulent Marek's disease viruses isolated in Japan.
    Imai K; Yuasa N; Iwakiri H; Nakamura K; Hihara H; Ishita T; Inamoto A; Okamoto I; Ohta K; Maeda M
    Avian Pathol; 1992; 21(1):119-26. PubMed ID: 18670921
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Relationship between Marek's disease virus load in peripheral blood lymphocytes at various stages of infection and clinical Marek's disease in broiler chickens.
    Islam AF; Walkden-Brown SW; Islam A; Underwood GJ; Groves PJ
    Avian Pathol; 2006 Feb; 35(1):42-8. PubMed ID: 16448942
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Marek's disease in turkeys: the induction of lesions and the establishment of lymphoid cell lines.
    Powell PC; Howes K; Lawn AM; Mustill BM; Payne LN; Rennie M; Thompson MA
    Avian Pathol; 1984 Apr; 13(2):201-14. PubMed ID: 18766837
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Protection of chickens from Newcastle and Marek's diseases with a recombinant herpesvirus of turkeys vaccine expressing the Newcastle disease virus fusion protein.
    Morgan RW; Gelb J; Schreurs CS; Lütticken D; Rosenberger JK; Sondermeijer PJ
    Avian Dis; 1992; 36(4):858-70. PubMed ID: 1485872
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Polyvalent Marek's disease vaccines: safety, efficacy and protective synergism in chickens with maternal antibodies.
    Witter RL; Lee LF
    Avian Pathol; 1984 Jan; 13(1):75-92. PubMed ID: 18766823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.